Artesunate
Cervix Intraepithelial Neoplasia Grade 3
UNC Lineberger Comprehensive Cancer CenterSmall moleculePhase 1Active
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Cervix Intraepithelial Neoplasia Grade 3 cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
TEGAFUR Institut Cancerologie de l'Ouest | Phase 3 | B |
Datopotamab Deruxtecan UNC Lineberger Comprehensive Cancer Center | Phase 2 | CCC |
Same molecule, other indications
Artesunate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →